Litcius/Paper detail

mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients

Zahra Bagheri‐Hosseinabadi, Ebrahim Rezazadeh Zarandi, Mohammad Mirabzadeh, Ali Amiri, Mitra Abbasifard

2022BMC Infectious Diseases32 citationsDOIOpen Access PDF

Abstract

BACKGROUND: The etiopathogenesis of coronavirus disease 2019 (COVID-19) stem partially from the abnormal activation of the innate and adaptive immune systems. Here in the current investigation, the mRNA expression levels of toll-like receptors (TLRs) were evaluated in the nasopharyngeal epithelial cells from COVID-19 patients. METHODS: Epithelial cells were obtained using nasopharyngeal swab samples from 90 COVID-19 patients and 50 controls. COVID-19 cases were classified into those without symptoms, with symptoms but not hospitalized, and with symptoms and hospitalized. To determine the mRNA expression levels of TLRs, first RNA was extracted and cDNA was synthesized, and finally Real-time PCR was exerted. RESULTS: It was seen that the transcript levels of TLR3, TLR7, TLR8, and TLR9 were overexpressed in the COVID-19 patients with clinical symptoms needing hospitalization as well as in those with clinical symptoms without needing for hospitalization compared to controls. Upregulation of TLRs was associated with clinical presentations of the patients. CONCLUSIONS: Modulation of TLR3, TLR7, TLR8, TLR9 in the epithelial cells of COVID-19 cases may estimate the disease severity and requirement for hospitalization.

Topics & Concepts

TLR9TLR3Toll-like receptorMessenger RNAReceptorInnate immune systemMedicineImmune systemImmunologyCoronavirusTLR7Downregulation and upregulationDiseaseCoronavirus disease 2019 (COVID-19)Internal medicineBiologyGene expressionGeneInfectious disease (medical specialty)DNA methylationBiochemistryCOVID-19 Clinical Research StudiesImmune Response and InflammationLong-Term Effects of COVID-19